RAPP
Precision, empathy, growth activation
- B2B
About RAPP
World leaders in activating growth for clients. Company achieves this growth with precision and empathy at a large scale.
Key facts
- Industry
- Advertising Services
- Company size
- 1,001–5,000 employees
- Headquarters
- New York, United States
- Founded
- 1965
- Revenue
- $50.5M – $1.3BTamtam estimate
- Website
- rapp.com
- linkedin.com/company/rapp
RAPP in the news
- Analysts Conflicted on These NA Names: General Dynamics (GD), Rapport Therapeutics, Inc. (RAPP) and First Solar (FSLR)
Analysts are conflicted on General Dynamics, while maintaining Buy ratings for Rapport Therapeutics and First Solar.
- Market Movers | Winners: QNC, EGHT, FSLY | Losers: CGEM, ALKT, RAPP
This article analyzes market movers, providing lists of top-performing and underperforming US stocks daily, weekly, and monthly, and advises investigating businesses behind ticker symbols instead of chasing performance.
- Rapport Therapeutics (RAPP) officer flags $553K stock sale plan
A Rapport Therapeutics officer plans to sell over $553,000 worth of company stock.
- Rapport Therapeutics (NASDAQ:RAPP) Reaches New 12-Month High - Should You Buy?
Rapport Therapeutics' stock hit a new 52-week high, driven by positive analyst ratings despite insider selling and a recent earnings miss, as the biopharmaceutical company continues its focus on cancer therapies.
- Rapport Therapeutics (RAPP) CEO Abraham Ceesay sells 51,499 shares via 10b5-1 plan
Rapport Therapeutics CEO Abraham Ceesay sold 51,499 shares of the company's common stock in August 2026, executed via a pre-arranged trading plan.
RAPP at a glance
RAPP is a B2B company in the Advertising Services industry, headquartered in New York, United States.
RAPP was founded in 1965.
RAPP has 1,001–5,000 employees.
RAPP's revenue is $50.5M – $1.3B (Tamtam estimate).
Selling to companies like RAPP?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies